JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tobe, C. E.
Right arrow Articles by Hofer, B. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tobe, C. E.
Right arrow Articles by Hofer, B. O.

The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 1007-1013, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study

CE Tobe, C Vocelka, R Sepulvada, B Gillis, M Nessly, ED Verrier and BO Hofer
Division of Cardiothoracic Surgery, University of Washington Medical Center, Seattle 98195.

Prior nonblinded studies have suggested dramatic hemostatic effects and decreased plasma after cardiopulmonary bypass. Platelet rich plasma (8 to 10 ml/kg total body weight) was obtained (Haemonetics Plasma Saver; Haemonetics Corp., Natick, Mass.) from 51 patients undergoing primary coronary artery bypass grafting before heparinization. After double- blinded randomization, the platelet rich plasma was reinfused immediately in the control group or after heparin reversal in the treatment group. Homologous blood product usage, blood loss, and the surgeon's intraoperative subjective assessment of coagulation were evaluated. Additionally, thromboelastography, prothrombin time, partial thromboplastin time, activated clotting time, fibrinogen, platelet counts, and hematocrit values were evaluated before the operation, after heparin reversal, after infusion of platelet rich plasma or control solution, and 2 hours after infusion. The surgeon's subjective assessment of coagulation was not different between control and treatment groups (p = 0.78). According to specific predetermined transfusion guidelines, no statistically significant differences were found in the use of whole blood (p = 0.07), packed red blood cells (p = 0.62), platelets (p = 0.11), total units of blood products (p = 0.45), or in the percentage of patients receiving transfusions (control group 70%, treatment group 71%, p = 0.97). Cumulative amount of blood shed through the chest tube was not significantly different between the groups at any interval but tended toward significance at 4, 6, and 12 hours (p = 0.09, 0.07, and 0.09). The prothrombin time immediately after reinfusion of platelet rich plasma was significantly lower in the treatment group (p = 0.03), but all other laboratory studies were similar at each time interval. Infusion of platelet rich plasma after cardiopulmonary bypass in patients having uncomplicated primary coronary artery bypass grafting has minimal effects on the surgeon's assessment of coagulation, total transfusion requirements, mediastinal drainage, and laboratory studies of coagulation.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2008; 3(2008): 415 - 430.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2003; 2(2003): 389 - 400.
[Full Text]


Home page
Anesth. Analg.Home page
P. R. Belcher, E. W. Muriithi, P. Wajon, and J. Gibson
Postoperative Bleeding After Coronary Artery Bypass Surgery with Cardiopulmonary Bypass * Response
Anesth. Analg., November 1, 2002; 95(5): 1466 - 1467.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Hiramatsu, T. Okamura, Y. Imai, H. Kurosawa, M. Aoki, T. Shin'oka, and Y. Takanashi
Effects of autologous platelet concentrate reinfusion after open heart surgery in patients with congenital heart disease
Ann. Thorac. Surg., April 1, 2002; 73(4): 1282 - 1285.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
K. Kottke-Marchant and S. Sapatnekar
Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 187 - 206.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
P. Wajon, J. Gibson, R. Calcroft, C. Hughes, and B. Thrift
Intraoperative Plateletpheresis and Autologous Platelet Gel Do Not Reduce Chest Tube Drainage or Allogeneic Blood Transfusion After Reoperative Coronary Artery Bypass Graft
Anesth. Analg., September 1, 2001; 93(3): 536 - 542.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. P. Stover, L. C. Siegel, P. A. Hood, G. E. O’Riordan, and T. R. McKenna
Platelet-Rich Plasma Sequestration, with Therapeutic Platelet Yields, Reduces Allogeneic Transfusion in Complex Cardiac Surgery
Anesth. Analg., March 1, 2000; 90(3): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. T. Christenson, J. Reuse, P. Badel, F. Simonet, and M. Schmuziger
Plateletpheresis Before Redo CABG Diminishes Excessive Blood Transfusion
Ann. Thorac. Surg., November 1, 1996; 62(5): 1373 - 1378.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. E. Helm, J. D. Klemperer, T. K. Rosengart, J. P. Gold, P. Peterson, W. DeBois, N. K. Altorki, S. Lang, S. Thomas, O. W. Isom, et al.
Intraoperative Autologous Blood Donation Preserves Red Cell Mass But Does Not Decrease Postoperative Bleeding
Ann. Thorac. Surg., November 1, 1996; 62(5): 1431 - 1441.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. P. Stover and L. C. Siegel
Platelet-rich plasmapheresis in cardiac surgery: Efficacy may yet be demonstrated
J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1148 - 1148.
[Full Text]


Home page
PerfusionHome page
Z. A Varga
Autologous plateletpheresis in cardiac surgery
Perfusion, November 1, 1993; 8(6): 471 - 476.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The American Association for Thoracic Surgery.